The recall involves lubricant eye drops under the Systane brand, manufactured by Alcon Laboratories, following a report of fungal material found in a sealed vial. No illnesses have been reported ...

The Food and Drug Administration (FDA) announced on Dec. 23 that Alcon Laboratories, based out of Texas, is voluntarily recalling a single lot of “Systane Lubricant Eye Drops Ultra SPF ...

Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...

Alcon said the Aerie deal is another example of its strategy to expand in the ophthalmic pharmaceutical eye drop space. "Aerie is a natural fit with on-market and pipeline products, and R&D ...

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed. Aurion will operate as ...

Alcon makes many of the most-credentialed, #1 Dr. recommended brands in the OTC eye care category. But business growth had declined 1%*, and there were further signs of stagnancy during back-to-school ...

Multinational eye care major Alcon is preparing to roll out multiple ... The company recorded net sales of $9.8 billion, a 5% increase over the previous year, or 6% on a constant currency basis.